Latest Valvular heart disease Stories

Transcatheter valve replacements are for patients at high-risk for traditional aortic valve replacement. Prior to the approval of TAVR, heart patients that were not healthy enough to undergo open-heart surgery had no long-term options for extending their lives. Jackson, TENN. (PRWEB) June 07, 2013 The week of May 13, a team of doctors working together through the West Tennessee Heart & Vascular Center (WTHVC) at Jackson-Madison County General Hospital performed the first three...

- Findings Published in the Journal of the American College of Cardiology Demonstrate Significant Improvements in Day-to-Day Quality of Life ABBOTT PARK, Ill., June 4, 2013 /PRNewswire/ -- Abbott today announced publication of positive outcomes from two European post-approval studies of the first-in-class catheter-based MitraClip(®) therapy for the treatment of mitral regurgitation (MR). Results from ACCESS-EU, a European prospective study that enrolled 567 patients at 14 sites,...

-Longer-Term Animal Data Suggests Tiara Device for the Transcatheter Treatment of Mitral Valve Disease Appears Safe and Well Tolerated TSX Venture Exchange: NVC PARIS and VANCOUVER, May 23, 2013 /CNW/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular disease, reported that positive animal data from its Tiara(TM) program for the transcatheter treatment of mitral valve disease was presented today at EuroPCR 2013, the annual meeting of the European...

New Data Presented In Late-Breaking Clinical Trial Session At EuroPCR Demonstrated Successful Deployment Of The Lotus(TM) Valve In The First 60 Patients With Minimal Paravalvular Regurgitation At 30 Days PARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus(TM) Valve System in symptomatic patients...

MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography, a new study indicates. The study included 69 patients who underwent an MDCT scan as well as transthoracic and transesophageal echocardiography before having a TAVI, said Dr. Vineeta Sethi, lead author of the study. TAVI is done to treat patients with severe aortic stenosis who are not surgical candidates....

INDIANAPOLIS, April 11, 2013 /PRNewswire-USNewswire/ -- Franciscan St. Francis Health is the first hospital in the United States to implant a new device that could improve the quality of life for patients with aortic valve disease. The On-X® Aortic Prosthetic Valve with Anatomic Sewing Ring is the most advanced mechanical heart valve and first to address the important concern of distorting the adjacent structures within the heart. The innovative valve is the only mechanical valve...

ABBOTT PARK, Ill., March 20, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted by majority (Yes: 5, No: 3) that the benefits of treatment with the MitraClip(®) device outweigh its risks in patients with significant symptomatic mitral regurgitation (MR) who have been determined by a cardiac surgeon to be too high risk for open mitral valve...

Even though young athletes are required to receive health screens to be cleared to play sports, those tests failed to detect important cardiovascular abnormalities in cleared players, and many were allowed to play despite suspicions of dangerous cardiovascular conditions, according to a large registry study of patients who died from sudden death, being presented March 10 by Kevin Harris, MD, research cardiologist at the Minneapolis Heart Institute Foundation (MHIF). The data is being...

The belief among medical professionals in the 1950s that the mortality rate for type A acute aortic dissection during the initial 24 hours was one to two percent per hour appears to hold true in the contemporary era of treatment, based on a review of the large-scale IRAD registry being presented March 9 at the American College of Cardiology (ACC) Scientific Sessions. "In the 1950s, the medical literature suggested that the mortality rate for type A acute aortic dissection was one percent...

SAN FRANCISCO, March 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip(®) System for the treatment of mitral regurgitation (MR). Findings were presented today at the 62nd Annual Scientific Session of the American College of Cardiology in San Francisco. Abbott's MitraClip system, an investigational device in the...